S&P Futures
3,659.75+36.50(+1.01%)Dow Futures
29,962.00+333.00(+1.12%)Nasdaq Futures
12,371.00+94.00(+0.77%)
Merck & Co., Inc. (MRK)
80.50 +0.11 (0.14%)
Before hours: 4:35AM EST
Chart Events
Performance Outlook
| Previous Close | 79.86 |
| Open | 80.00 |
| Bid | 80.68 x 800 |
| Ask | 0.00 x 1000 |
| Day's Range | 79.41 - 80.54 |
| 52 Week Range | 65.25 - 92.64 |
| Volume | 10,957,775 |
| Avg. Volume | 8,510,577 |
| Market Cap | 203.389B |
| Beta (5Y Monthly) | 0.43 |
| PE Ratio (TTM) | 17.75 |
| EPS (TTM) | 4.53 |
| Earnings Date | Feb 04, 2021 |
| Forward Dividend & Yield | 2.60 (3.26%) |
| Ex-Dividend Date | Dec 14, 2020 |
| 1y Target Est | 95.58 |
- Insider Monkey
Is Merck (MRK) A Good Stock To Buy Now?
Most investors tend to think that hedge funds and other asset managers are worthless, as they cannot beat even simple index fund portfolios. In fact, most people expect hedge funds to compete with and outperform the bull market that we have witnessed in recent years. However, hedge funds are generally partially hedged and aim at […]
- Business Wire
Merck to Present at the 2020 Evercore ISI 3rd Annual HealthCONx Virtual Conference
Merck to Present at the 2020 Evercore ISI 3rd Annual HealthCONx Virtual Conference
- Zacks Small Cap Research
TNXP: Animal Data for SARS-CoV-2 Vaccine Candidate Shows Robust Immune Response…
By David Bautz, PhD NASDAQ:TNXP READ THE FULL TNXP RESEARCH REPORT Business Update TNX-1800 Generates Positive Immune Response in Non-Human Primates On November 16, 2020, Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) announced a positive immune response in all eight animals vaccinated with TNX-1800, the company’s lead COVID-19 vaccine candidate. Each of the vaccinated animals developed a
